BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Gan&Lee Doses First Participant in Phase I Trial of Once-Weekly Oral GLP-1 Candidate GZC8072

Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a First-In-Human (FIH...

September 11, 2026 | News

Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. ...

September 10, 2026 | News

The Arbitrage Triangle

METHOD IN BRIEF Flow estimates come from published government statistics and press reporting of official material; no authority in the region publishes in...

September 09, 2026 | Analysis

CorrectSequence’s Base-Editing Therapy Shows Durable Response Across Diverse β-Hemoglobinopathy Patients

Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT pati...

September 09, 2026 | News

Huawei Launches Four AI+ Healthcare Solutions at HIMSS26 APAC

HIMSS26 APAC a flagship digital health event for the Asia-Pacific region at Marina Bay Sands Expo and Convention Centre in Singapore. During the event, Hua...

September 09, 2026 | News

Where the Longevity Money Actually Goes

METHOD IN BRIEF Window: 1 January to 31 August 2026 for round-level claims, with full-year 2024 and 2025 figures for context. Attribution follows scientif...

September 07, 2026 | Analysis

GE HealthCare, Tucker Medical Partner to Advance Imaging Excellence in Southeast Asia

Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia Tucker Medical has installed a SIGNA&trad...

September 07, 2026 | News

Nobody Is the Payer

A gerotherapeutic that delays five diseases by three years each would produce savings across five budget lines over thirty years, and a cost that lands in ...

September 04, 2026 | Analysis

8 Reasons Fall Is the Perfect Time To Reassess Your Health Goals

With cooler weather, changing schedules, and renewed motivation, it's an ideal season to establish habits that can carry you through the holidays and beyon...

September 02, 2026 | News

Hims & Hers Enters APAC Market with Australia Launch Following Eucalyptus Acquisition

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, announced it is now serving customers in Australia, marki...

September 03, 2026 | News

Singapore Becomes First ASEAN Market to Subsidise Vutrisiran for ATTR Amyloidosis

"From September 2026 – eligible patients receiving vutrisiran will receive government subsidies of up to 75%[1],[2]" "HELIOS-A and B provide strong ...

September 02, 2026 | News

Convergen Raises $15M Seed+ to Accelerate Targeted Protein Degradation Therapies

Convergen, a biotechnology company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, an...

September 02, 2026 | News

Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain

Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...

September 02, 2026 | News

Making a Drug People Take for Twenty Years

METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a cost-of-goods figure and none is...

September 01, 2026 | News

Stay Connected